Johan Botling
Uppsala University · 346 works · 13,995 citations · h-index 54
Top works
- Comprehensive genomic profiles of small cell lung cancer
- In situ sequencing for RNA analysis in preserved tissue and cells
- PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project
- HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGF
- Somatically mutated Ig VH3-21 genes characterize a new subset of chronic lymphocytic leukemia
- Biobanking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens
- A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee
- A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin κ C as a Compatible Prognostic Marker in Human Solid Tumors
- In Situ Detection of Phosphorylated Platelet-derived Growth Factor Receptor β Using a Generalized Proximity Ligation Method
- Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation
- PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee
- Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter
- The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer
- Functional antagonism between vitamin D3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells
- Targeted resequencing of candidate genes using selector probes
- The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
- Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity
- Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance
- Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11
- Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer